Exact Therapeutics AS (OSL:EXTX) Total Liabilities : kr16.22 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Total Liabilities?

Exact Therapeutics AS's Total Liabilities for the quarter that ended in Dec. 2023 was kr16.22 Mil.

Exact Therapeutics AS's quarterly Total Liabilities declined from Dec. 2022 (kr17.40 Mil) to Jun. 2023 (kr7.81 Mil) but then increased from Jun. 2023 (kr7.81 Mil) to Dec. 2023 (kr16.22 Mil).

Exact Therapeutics AS's annual Total Liabilities increased from Dec. 2021 (kr11.89 Mil) to Dec. 2022 (kr17.40 Mil) but then declined from Dec. 2022 (kr17.40 Mil) to Dec. 2023 (kr16.22 Mil).

Exact Therapeutics AS Total Liabilities Historical Data

The historical data trend for Exact Therapeutics AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Total Liabilities Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

9.87

10.58

11.89

17.40

16.22

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial						11.89	15.38	17.40	7.81	16.22

Exact Therapeutics AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Exact Therapeutics AS's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.486	+	(0.65	+	0.081999999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	16.22

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	61.319	-	45.101
	=	16.22

Exact Therapeutics AS's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.486	+	(0.65	+	0.081999999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	16.22

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	61.319	-	45.101
	=	16.22

Exact Therapeutics AS Total Liabilities Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines